AU686394B2 - Human monoclonal antibodies specific to cell cycle independent glioma surface antigen - Google Patents

Human monoclonal antibodies specific to cell cycle independent glioma surface antigen Download PDF

Info

Publication number
AU686394B2
AU686394B2 AU27092/95A AU2709295A AU686394B2 AU 686394 B2 AU686394 B2 AU 686394B2 AU 27092/95 A AU27092/95 A AU 27092/95A AU 2709295 A AU2709295 A AU 2709295A AU 686394 B2 AU686394 B2 AU 686394B2
Authority
AU
Australia
Prior art keywords
seq
amino acid
immunoglobulin
glioma
chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU27092/95A
Other languages
English (en)
Other versions
AU2709295A (en
Inventor
Michael D. Dan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Viventia Bio Inc
Original Assignee
Viventia Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viventia Biotech Inc filed Critical Viventia Biotech Inc
Publication of AU2709295A publication Critical patent/AU2709295A/en
Application granted granted Critical
Publication of AU686394B2 publication Critical patent/AU686394B2/en
Assigned to NOVOPHARM BIOTECH INC. reassignment NOVOPHARM BIOTECH INC. Alteration of Name(s) in Register under S187 Assignors: DAN, MICHAEL D.
Assigned to VIVENTIA BIOTECH INC. reassignment VIVENTIA BIOTECH INC. Request to Amend Deed and Register Assignors: NOVOPHARM BIOTECH INC.
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3053—Skin, nerves, brain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/863—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgM
    • Y10S530/864—Monoclonal
    • Y10S530/865—Human
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/866—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving immunoglobulin or antibody fragment, e.g. fab', fab, fv, fc, heavy chain or light chain

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU27092/95A 1994-06-21 1995-06-16 Human monoclonal antibodies specific to cell cycle independent glioma surface antigen Ceased AU686394B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US264093 1994-06-21
US08/264,093 US5639863A (en) 1994-06-21 1994-06-21 Human monoclonal antibodies specific to cell cycle independent glioma surface antigen
PCT/CA1995/000361 WO1995035374A1 (en) 1994-06-21 1995-06-16 Human monoclonal antibodies specific to cell cycle independent glioma surface antigen

Publications (2)

Publication Number Publication Date
AU2709295A AU2709295A (en) 1996-01-15
AU686394B2 true AU686394B2 (en) 1998-02-05

Family

ID=23004543

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27092/95A Ceased AU686394B2 (en) 1994-06-21 1995-06-16 Human monoclonal antibodies specific to cell cycle independent glioma surface antigen

Country Status (12)

Country Link
US (1) US5639863A (zh)
EP (1) EP0766736B1 (zh)
JP (1) JPH10501411A (zh)
CN (1) CN1074458C (zh)
AT (1) ATE205532T1 (zh)
AU (1) AU686394B2 (zh)
CA (1) CA2192079C (zh)
DE (1) DE69522689T2 (zh)
MX (1) MX9605895A (zh)
NO (1) NO965395L (zh)
NZ (1) NZ288157A (zh)
WO (1) WO1995035374A1 (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE403001T1 (de) 1996-05-22 2008-08-15 Viventia Biotech Inc Antigenbindungsfragmente die spezifisch krebszellen nachweisen, nukleotide die für diese fragmente kodieren, und deren verwendung zur vorbeugung und zum nachweis von krebs
US7115722B1 (en) 1997-05-22 2006-10-03 Viventia Biotech, Inc. Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
EP1007967A2 (en) * 1997-08-04 2000-06-14 Ixsys, Incorporated Methods for identifying ligand specific binding molecules
US7109170B2 (en) * 1999-06-16 2006-09-19 Saint Louis University Region of factor IXa protease domain that interacts with factor VIIIa and methods therefor
AU7262700A (en) * 1999-09-07 2001-04-10 Viventia Biotech Inc. Enhanced phage display library of human vh fragments and methods for producing same
CA2447832C (en) * 2000-12-22 2012-09-25 Jamshid Tanha Phage display libraries of human vh fragments
DE10210427A1 (de) * 2002-03-09 2003-10-09 Hans Konrad Mueller-Hermelink Humaner monoklonaler Antikörper
EP2322559A3 (en) * 2002-07-04 2011-08-03 Patrys Limited Neoplasm specific antibodies and uses thereof
DE10311248A1 (de) * 2003-03-14 2004-09-30 Müller-Hermelink, Hans Konrad, Prof. Dr. Humaner monoklonaler Antikörper
NZ577824A (en) * 2003-11-12 2010-10-29 Patrys Ltd Methods of identifying neoplasm-specific antibodies and uses thereof
EP1531162A1 (en) * 2003-11-14 2005-05-18 Heinz Vollmers Adenocarcinoma specific antibody SAM-6, and uses thereof
DE10353175A1 (de) * 2003-11-14 2005-06-16 Müller-Hermelink, Hans Konrad, Prof. Dr. Humaner monoklonaler Antikörper mit fettsenkender Wirkung
DE102004015179A1 (de) * 2004-03-25 2005-10-13 Oncomab Gmbh Antigen des PM-2 Antikörpers und dessen Verwendung
CL2007002668A1 (es) * 2006-09-20 2008-05-09 Amgen Inc Proteina de union a antigeno que se une al receptor de glucagon humano; acido nucleico que la codifica; metodo de produccion; composicion farmaceutica que la comprende; y su uso para tratar o prevenir la diabetes tipo 2.
AU2007301599B2 (en) 2006-09-28 2013-01-10 Merck Serono S.A. Junctional Adhesion Molecule-C (JAM-C) binding compounds and methods of their use
JP2010510772A (ja) * 2006-11-27 2010-04-08 パトリス リミテッド 新生細胞における新規なグリコシル化ペプチド標的
AU2010210312A1 (en) * 2009-02-09 2011-08-04 Patrys Limited SAM-6 variants, target and methods of use
CN103127528B (zh) * 2012-09-14 2016-04-20 苏州大学 人类dcx基因在制备胶质瘤放疗增敏剂中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2035088A1 (en) * 1990-01-29 1991-07-30 Michael D. Dan Human monoclonal antibodies for brain tumor diagnosis and therapy

Also Published As

Publication number Publication date
EP0766736B1 (en) 2001-09-12
AU2709295A (en) 1996-01-15
JPH10501411A (ja) 1998-02-10
NO965395D0 (no) 1996-12-13
NZ288157A (en) 1999-09-29
NO965395L (no) 1996-12-17
MX9605895A (es) 1997-12-31
ATE205532T1 (de) 2001-09-15
CA2192079C (en) 2001-01-09
US5639863A (en) 1997-06-17
DE69522689D1 (de) 2001-10-18
EP0766736A1 (en) 1997-04-09
CN1151184A (zh) 1997-06-04
CN1074458C (zh) 2001-11-07
CA2192079A1 (en) 1995-12-28
DE69522689T2 (de) 2002-08-08
WO1995035374A1 (en) 1995-12-28

Similar Documents

Publication Publication Date Title
AU686394B2 (en) Human monoclonal antibodies specific to cell cycle independent glioma surface antigen
Van De Rijn et al. Mouse hematopoietic stem-cell antigen Sca-1 is a member of the Ly-6 antigen family.
Carrel et al. Subsets of human Ia-like molecules defined by monoclonal antibodies
Fleming et al. Selective expression of Ly-6G on myeloid lineage cells in mouse bone marrow. RB6-8C5 mAb to granulocyte-differentiation antigen (Gr-1) detects members of the Ly-6 family.
US4434156A (en) Monoclonal antibodies specific for the human transferrin receptor glycoprotein
KR100227303B1 (ko) 인체 t 임파구 수용체의 베타 사슬의 가변성 영역을 코딩하는 뉴클레오티드 서열, 대응하는 펩티드 세그먼트 및 진단 및 치료 용도
US7517966B2 (en) Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells and antibodies that identify the same
Campbell et al. Molecular cloning of the B-CAM cell surface glycoprotein of epithelial cancers: a novel member of the immunoglobulin superfamily
WO1991006570A1 (en) HYBRID Fc RECEPTOR MOLECULES
EP0660721A1 (en) Monoclonal antibodies that block ligand binding to the cd22 receptor in mature b cells
EP1233785A1 (en) "bonzo" chemokine receptor antibodies and ligands
EP0203403B1 (en) A cloned t cell capable of recognizing tumors and a t cell antigen receptor
EP1240326B1 (en) Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells and antibodies that identify this receptor
NZ264003A (en) Interleukin-12 receptor protein and dna, immunoglobulin capable of binding the protein and pharmaceutical compositions
Devaux et al. Generation of monoclonal antibodies against soluble human T cell receptor polypeptides
EP0726914B1 (en) Cell surface protein expressed on human cortical thymocyte and their use
EP0462111A1 (en) Homing sequences and their uses
von Hoegen et al. Identity of human Lyb‐2 and CD72 and localization of the gene to chromosome 9
Ashmun et al. Expression of the human monocyte membrane antigen gp55 by murine fibroblasts after DNA-mediated gene transfer
WO1998021240A1 (en) Recombinant by55 and nucleic acids encoding same
Bicknell et al. Monoclonal antibodies specific for a tumor-associated membrane phosphoprotein in human cell hybrids
US20030068628A1 (en) Nucleotide sequences coding for variable regions of beta chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses
Kaluza et al. A general method for chimerization of monoclonal antibodies by inverse polymerase chain reaction which conserves authentic N-terminal sequences
CA2288307C (en) Novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells and antibodies that identify the same
MARLAND et al. 17. CHARACTERISATION OF A MOLECULE INVOLVED IN CELL ACTIVATION AND ADHESION

Legal Events

Date Code Title Description
HB Alteration of name in register

Owner name: VIVENTIA BIOTECH INC.

Free format text: FORMER NAME WAS: NOVOPHARM BIOTECH INC.

MK14 Patent ceased section 143(a) (annual fees not paid) or expired